Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Singular Genomics Systems to similar companies based on the strength of its valuation, institutional ownership, profitability, earnings, risk, analyst recommendations and dividends. Profitability This table compares […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “Singular Genomics Systems Inc. is a life science technology company. It focused on delivering genomic technologies for the advancement of science and medicine. […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Singular Genomics Systems to similar companies based on the strength of its earnings, analyst recommendations, dividends, valuation, institutional ownership, risk and profitability. Insider and Institutional Ownership […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Singular Genomics Systems to related businesses based on the strength of its earnings, risk, profitability, institutional ownership, dividends, analyst recommendations and valuation. Earnings and […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) had its target price decreased by The Goldman Sachs Group from $17.00 to $11.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of 109.13% from the […]